Red cell transfusions: Is less always best?: How confident are we that restrictive transfusion strategies should be the standard of care default transfusion practice?

Abstract

AM, SS, JS, EW, and ZM are authors of papers discussed in this article, and are also investigators on the REDDS-2 trial, which is discussed in this article. SS, EW, and ZM were investigators on the REDDS trial, which is also discussed in this article.